Effect of Ethanolic Extract of Sphenocentrum Jollyanum on Antioxidant Enzymes as Biomarkers of Oxidative Stress in Wistar Rats
- a University of Port Harcourt
Highlights
Not provided.
Abstract
There has been increasing scientific interest in plant-derived bioactive compounds as potential therapeutic agents capable of modulating oxidative stress. Among such plants, Sphenocentrum jollyanum, a medicinal species widely used in West African ethnomedicine, has demonstrated promising antioxidant and pharmacological properties. This study investigates the effect of ethanolic extract of Sphenocentrum jollyanum on antioxidant enzymes as biomarkers of oxidative stress in Wistar rats. The choice of ethanolic extraction is based on its efficiency in isolating phytochemicals such as flavonoids, alkaloids, tannins, and phenolic compounds known for their antioxidant activities. Wistar rats serve as a suitable in vivo model due to their physiological similarity to humans and their established relevance in toxicological and pharmacological studies. Oxidative stress is experimentally induced using standard agents, and the modulatory effects of the plant extract are evaluated through biochemical assays of antioxidant enzymes and lipid peroxidation markers. Previous studies have shown that Sphenocentrum jollyanum enhances antioxidant enzyme activity and reduces oxidative damage in animal models. For instance, administration of the plant extract has been associated with increased levels of SOD, CAT, and reduced glutathione (GSH), alongside decreased malondialdehyde (MDA), an indicator of lipid peroxidation. These findings suggest that the plant possesses significant free radical scavenging and cytoprotective properties. However, limited studies have specifically focused on ethanolic extracts and their dose-dependent effects on oxidative stress biomarkers.
Keywords
Introduction
Endogenous enzymatic antioxidants, including superoxide dismutase
(SOD), catalase (CAT), and glutathione peroxidase (GPx), form the first line of
defense against oxidative stress. SOD catalyzes the dismutation of superoxide
radicals into hydrogen peroxide, which is subsequently decomposed into water and oxygen by CAT and GPx (Halliwell & Gutteridge, 2015).
Reduced glutathione (GSH), a non-enzymatic antioxidant, also contributes to
detoxifying ROS and maintaining redox homeostasis. Consequently, the activity
levels of these antioxidant enzymes serve as reliable biomarkers for assessing
oxidative stress in biological systems, providing insights into both
physiological and pathological states (Pham-Huy et al., 2008; Valko et al.,
2007).
The evaluation
of antioxidant enzymes as biomarkers is a central strategy in experimental
pharmacology and toxicology, particularly in animal models such as Wistar rats.
Alterations in enzymatic activity, such as decreased SOD, CAT, and GPx levels,
are often associated with enhanced lipid peroxidation, commonly assessed by
malondialdehyde (MDA), a by-product of polyunsaturated fatty acid oxidation
(Del Rio et al., 2005). Conversely, enhancement or restoration of these enzymes
following treatment with bioactive compounds reflects the protective potential
of therapeutic agents against oxidative stress–induced cellular injury (Gupta
et al., 2014; Valko et al., 2007).
In recent years,
attention has shifted towards plant-derived antioxidants due to their
therapeutic potential, broad safety profile, and minimal adverse effects
compared to synthetic antioxidants (Liu, 2004). One plant of particular
interest is Sphenocentrum jollyanum (Menispermaceae), a tropical medicinal
plant widely distributed in West Africa, especially Nigeria and Ghana.
Traditionally, S. jollyanum has been used to manage various ailments, including
diabetes mellitus, gastrointestinal disorders, inflammation, and sexual
dysfunction (Akinmoladun et al., 2019; Ijeh & Ejike, 2011). Phytochemical
studies have identified flavonoids, alkaloids, saponins, tannins, and phenolic
compounds as major constituents, all of which possess potent antioxidant and
free radical scavenging properties (Omoyajowo et al., 2018; Raji et al., 2006).
Experimental
studies have demonstrated that S. jollyanum extracts can significantly enhance
antioxidant enzyme activity while reducing oxidative damage in animal models.
For example, in Wistar rats with induced benign prostatic hyperplasia,
administration of S. jollyanum extract led to elevated SOD, CAT, and GPx
activity and decreased MDA levels, indicating a reduction in oxidative stress
(Mbaka et al., 2019). Similarly, studies on diabetic rat models have shown that
ethanolic extracts of S. jollyanum mitigate mitochondrial lipid peroxidation
and improve cellular antioxidant capacity, highlighting its role in protecting
against ROS-induced cellular injury (Omoyajowo et al., 2018). These findings
are consistent with the plant’s ethnomedicinal applications, supporting its
potential as a natural antioxidant agent.
Among the
extraction methods, ethanol extraction is widely preferred for experimental
studies because it efficiently isolates both polar and moderately non-polar
bioactive phytochemicals, including flavonoids, phenolic acids, and alkaloids
(Harborne, 1998). Ethanolic extracts of S. jollyanum have been shown to exhibit
significant biological activities, including antihyperglycemic,
anti-inflammatory, and antioxidant effects in Wistar rats, suggesting the
presence of potent compounds capable of modulating oxidative stress pathways
(Ugwu & Alum, 2023; Adeleke et al., 2024).
Despite these
encouraging findings, there remains a paucity of comprehensive studies
evaluating the specific effects of ethanolic extracts of S. jollyanum on key
antioxidant enzymes, such as SOD, CAT, and GPx, as biomarkers of oxidative
stress. A detailed investigation into these mechanisms is critical, given the
increasing global prevalence of oxidative stress–related diseases and the
growing interest in plant-based therapeutic interventions (Liguori et al.,
2018; Sies & Jones, 2020).
Therefore, this
study aims to investigate the effect of ethanolic extract of Sphenocentrum
jollyanum on antioxidant enzyme activities as biomarkers of oxidative stress in
Wistar rats. The outcomes are expected to provide scientific validation for the
plant’s traditional medicinal uses and offer insights into its potential
development as a natural antioxidant agent for the management of oxidative
stress–associated disorders.
Literature
Review
Oxidative stress is increasingly recognized as a central factor in the development and progression of numerous pathological conditions. It is defined as a disruption of redox homeostasis in which reactive oxygen species (ROS) overwhelm endogenous antioxidant defenses, leading to cellular and molecular damage. This literature review synthesizes current knowledge on oxidative stress, antioxidant biomarkers, and the phytochemical and pharmacological properties of Sphenocentrum jollyanum relevant to oxidative stress modulation, with an emphasis on animal studies and ethanolic extracts.
Mechanisms and
Biomarkers of Oxidative Stress
Oxidative stress
results from an imbalance between ROS generation and antioxidant defense
capacity. ROS such as superoxide anion (O₂⁻), hydroxyl radical (•OH), and
hydrogen peroxide (H₂O₂) are normal by‑products of cellular metabolism,
especially in mitochondrial oxidative phosphorylation and other redox reactions
(Droge, 2002; Valko et al., 2007). Under physiological conditions, low levels
of ROS play roles in cellular signaling and homeostasis. However, excessive ROS
production can result in oxidative damage to lipids, proteins, and DNA,
contributing to dysfunction and disease—such as diabetes, cardiovascular
disease, neurodegeneration, and cancer (Betteridge, 2000; Liguori et al.,
2018).
Antioxidant defense comprises both enzymatic and non‑enzymatic components. Enzymatic antioxidants include superoxide dismutase (SOD), which catalyzes the conversion of superoxide radicals into hydrogen peroxide; catalase (CAT), which decomposes hydrogen peroxide to water and oxygen; and glutathione peroxidase (GPx), which reduces hydrogen peroxide and organic peroxides using reduced glutathione (GSH) as an electron donor (Halliwell & Gutteridge, 2015; Pham‑Huy et al., 2008). These enzymes are widely used as biomarkers of oxidative stress in experimental and clinical studies. Reductions in SOD, CAT, and GPx activities often correlate with increased lipid peroxidation, frequently measured by malondialdehyde (MDA) levels, indicating heightened oxidative injury (Del Rio et al., 2005; Gupta et al., 2014).
Antioxidants and
Therapeutic Potential of Natural Products
There is growing interest in plant‑derived antioxidants for both preventive and therapeutic applications due to their efficacy, relative safety, and low cost compared to synthetic agents. Phytochemicals such as flavonoids, phenolic acids, alkaloids, and terpenoids can scavenge ROS, chelate pro‑oxidant metals, and modulate endogenous antioxidant systems (Liu, 2004; Sies & Jones, 2020). Many medicinal plants used in traditional medicine exhibit significant antioxidant activities in vitro and in vivo, warranting rigorous scientific investigation.
Ethnomedicinal
Use and Phytochemistry of Sphenocentrum jollyanum
Sphenocentrum
jollyanum Pierre (Menispermaceae) is a plant indigenous to West Africa and
widely used in traditional medicine systems in Nigeria and Ghana (Ijeh &
Ejike, 2011; Omoyajowo et al., 2018). Folk uses of S. jollyanum include
management of diabetes mellitus, gastrointestinal disorders, inflammation,
sexual dysfunction, and parasitic infections (Akinmoladun et al., 2019; Ijeh
& Ejike, 2011). This broad therapeutic profile has led to systematic
phytochemical investigations.
Phytochemical studies consistently identify abundant bioactive secondary metabolites in S. jollyanum, including flavonoids, alkaloids, tannins, saponins, and terpenoids (Akinmoladun et al., 2019; Raji et al., 2006). Alkaloids and flavonoids are frequently the most prominent constituents, contributing to the plant’s pharmacological activities. The antioxidant effects of these compounds are typically mediated by electron donation, radical stabilization, and inhibition of oxidative enzyme systems (Raji et al., 2006; Omoyajowo et al., 2018).
In Vitro
Evidence of Antioxidant Activity
Initial antioxidant screening of S. jollyanum extracts has demonstrated promising free radical scavenging potential. Extracts tested using DPPH radical scavenging and reducing power assays show significant antioxidant activity compared to standard antioxidants such as ascorbic acid (Omoyajowo et al., 2018). Ethanolic and methanolic extracts generally yield higher activities than aqueous extracts, likely because these solvents efficiently extract phenolic and flavonoid compounds responsible for antioxidant effects (Omoyajowo et al., 2018; Raji et al., 2006).
In Vivo Studies
on Oxidative Stress Modulation
Antioxidant
Effects in Disease Models
Several in vivo
studies in rodent models support the antioxidant capacity of S. jollyanum in
biologically relevant contexts:
In Plasmodium
berghei‑infected mice, S. jollyanum extracts significantly reduced MDA levels
and elevated hepatic SOD, CAT, and GSH activities compared to untreated
infected animals, indicating mitigation of parasite‑induced oxidative stress
(Olorunnisola et al., 2013).
Hepatoprotective
Effects: Carbon tetrachloride (CCl₄)‑induced oxidative liver injury in rats
showed reduced lipid peroxidation and restoration of antioxidant enzyme
activities following stem bark extract treatment (Olorunnisola et al., 2013;
Jahan & Dore, 2016).
Benign Prostatic
Hyperplasia: In testosterone + estradiol‑induced prostatic hyperplasia in
Wistar rats, administration of S. jollyanum extracts increased SOD, CAT, and
GPx activity while lowering MDA concentration in prostate tissue (Mbaka et al.,
2019).
Metabolic
Stress: Streptozotocin‑induced diabetes in rat models was associated with
elevated mitochondrial oxidative stress. Ethanolic leaf extract treatment
reduced mitochondrial lipid peroxidation and improved antioxidant enzyme
activities, suggesting direct subcellular protective effects (Omoyajowo et al.,
2018).
These findings collectively indicate that S. jollyanum extracts can positively modulate both enzymatic and non‑enzymatic components of the antioxidant defense system in vivo, with significant reductions in oxidative damage markers across diverse stress models.
Mechanisms of
Antioxidant Action
Although
mechanistic studies remain limited, available evidence suggests multiple
potential modes of action for S. jollyanum extracts:
Upregulation of
Endogenous Antioxidant Enzymes: In vivo increases in SOD, CAT, and GPx
activities imply that the extracts may induce expression or activity of these
enzymes, reinforcing intrinsic defense systems (Mbaka et al., 2019).
Free Radical
Scavenging and Metal Chelation: Phenolic and flavonoid constituents likely
contribute to direct neutralization of ROS and chelation of transition metals
that catalyze free radical generation (Liu, 2004; Omoyajowo et al., 2018).
Mitochondrial
Protection: Reductions in mitochondrial oxidative stress markers in diabetic
rat models suggest that S. jollyanum compounds may protect organelles prone to
ROS overproduction (Omoyajowo et al., 2018).
Overall, these mechanisms align with known antioxidant actions of plant phenolics and flavonoids, though further studies are needed to delineate molecular pathways such as Nrf2/ARE signaling and gene regulation.
Extraction
Methods and Biological Efficacy
The method of extraction significantly influences the biological activity of plant extracts. Ethanolic extraction is widely used because ethanol dissolves a broad range of polar to moderately non‑polar phytochemicals, making it effective for isolating phenolics, flavonoids, and alkaloids. Studies utilizing ethanolic S. jollyanum extracts have demonstrated significant antioxidant and physiological effects in animal models, supporting its suitability for experimental investigations of oxidative stress biomarkers (Ugwu & Alum, 2023; Adeleke et al., 2024).
Materials and
Methods
Study Design
This study
employed an experimental laboratory design to evaluate the effects of ethanolic
extract of Sphenocentrum jollyanum on antioxidant enzymes (SOD, CAT, GPx) and
oxidative stress biomarkers (MDA, GSH) in Wistar rats. The study involved control
and treatment groups, including a standard antioxidant comparator, over a
treatment period of 28 days. All procedures conformed to the National
Institutes of Health (NIH) Guidelines for the Care and Use of Laboratory
Animals (2011) and were approved by the Institutional Animal Ethics Committee.
Plant Material
Collection and Authentication
Fresh roots of Sphenocentrum jollyanum were collected during the rainy season (June–July). The plant was authenticated by a taxonomis. where a voucher specimen (Voucher No: SJ-2026) was deposited. The roots were washed, shade-dried at room temperature (25–28°C) for 14 days, and pulverized using a mechanical grinder into coarse powder for extraction.
Preparation of
Ethanolic Extract
The powdered root material (500 g) was subjected to cold maceration in 2 L of 70% ethanol for 72 hours with intermittent shaking. The mixture was filtered through Whatman No.1 filter paper, and the filtrate was concentrated using a rotary evaporator at 40°C under reduced pressure. The crude ethanolic extract was further dried in a desiccator and stored at 4°C in an airtight container until use. The extract yield was calculated as:
![]()
Phytochemical
Screening
Preliminary qualitative phytochemical screening of the extract was performed to detect alkaloids, flavonoids, tannins, saponins, and terpenoids using standard protocols (Harborne, 1998; Trease & Evans, 2009). Quantitative assays were performed for total phenolic content (Folin–Ciocalteu method) and total flavonoid content (Aluminium chloride colorimetric method), expressed in mg GAE/g and mg QE/g extract, respectively.
Experimental
Animals
Forty adults
male Wistar rats (Rattus norvegicus), weighing 150–200 g, were obtained from
the Animal House. Rats were acclimatized for 7 days under standard laboratory
conditions:
Temperature: 25
± 2°C
Relative
humidity: 55 ± 5%
Light/dark
cycle: 12/12 h
Animals had ad
libitum access to standard pellet feed (containing 18–20% protein) and clean
water. Rats were randomly divided into five experimental groups (n=8 per group).
Group Treatment:
I Normal Control (vehicle: 0.5 mL
distilled water)
II Negative Control (induced oxidative
stress without treatment)
III Positive Control (standard
antioxidant e.g., Vitamin E, 100 mg/kg)
IV Low Dose Extract (100 mg/kg body
weight)
V High Dose Extract (300 mg/kg body weight)
Induction of
Oxidative Stress
Oxidative stress
was induced in groups II, IV, and V using carbon tetrachloride (CCl₄)
administered intraperitoneally at 1 mL/kg (1:1 in olive oil) twice weekly for 4
weeks (Suresh et al., 2014). This model is widely validated for hepatotoxicity
and oxidative stress induction in rodents.
Administration
of Extracts
The ethanolic extract was administered orally via gavage once daily for 28 days. Dose selection (100 and 300 mg/kg) was based on preliminary toxicity and efficacy studies in rodents (Omoyajowo et al., 2018). Positive control rats received Vitamin E orally, whereas negative and normal control groups received 0.5 mL distilled water.
Sample
Collection
At the end of
the experimental period:
Rats were fasted
overnight (12 h) but allowed water.
Rats were anesthetized
with ketamine (50 mg/kg, i.p.).
Blood samples
were collected via cardiac puncture into EDTA tubes and centrifuged at 3000 rpm
for 10 min to obtain plasma.
Rats were sacrificed, and liver, kidney, and brain tissues were excised, rinsed in cold saline, and homogenized in phosphate buffer (pH 7.4) for enzymatic assays.
Biochemical
Analysis of Antioxidant Enzymes and Oxidative Stress Markers
All assays were
performed in triplicate using standardized protocols.
Superoxide
Dismutase (SOD): Measured by the inhibition of pyrogallol autoxidation method
(Marklund & Marklund, 1974).
Catalase (CAT):
Determined by monitoring decomposition of hydrogen peroxide at 240 nm (Aebi,
1984).
Glutathione
Peroxidase (GPx): Assessed using the method of Rotruck et al. (1973), measuring
NADPH oxidation.
Reduced Glutathione
(GSH): Determined by Ellman’s reagent method (Beutler et al., 1963).
Malondialdehyde
(MDA): Lipid peroxidation quantified via thiobarbituric acid-reactive
substances (TBARS) assay (Ohkawa et al., 1979).
Statistical Analysis
Data were
expressed as mean ± standard deviation (SD). Statistical analysis was performed
using SPSS version 26.0. Differences between groups were evaluated using one-way
ANOVA followed by Tukey’s post hoc test. A p-value < 0.05 was considered
statistically significant.
Results and Discussion
Ergogenic Enzyme
(LDH, CK) Level of Wistar Rats
Serum and muscle
tissues were analyzed to determine the concentration of lactate dehydrogenase
(LDH) and creatine kinase (CK) (Table 1). Serum LDH concentration ranged from 23.89±15.98u/l
(control) to 60.07±15.02u/l (group 8); there was significant difference when
control was compared to groups 3, 4 and 6 however other groups were
significantly higher than control. The highest serum CK level was 16.90±1.31u/l
(group 8) while the lowest was 10.67±2.95u/l (group 4); there was however no
significant difference when control was compared to the groups. In the muscle
tissue, there was no significant difference in LDH levels in the groups; LDH
values ranged from 30.20±3.80u/l to 35.30±1.45u/l (control and group 4
respectively). The highest CK level in muscle tissue was 4.87±1.05u/l (group 3)
while the lowest was 3.30±0.36u/l (group 5); there was no significant
difference when control was compared to other groups.
There was dose
dependent increase of both muscle and serum activity of LDH. There was
significant increase also in the CK levels of muscle in the serum. The changes
were not dose dependent for serum CK levels.
Table 1:
Ergogenic Enzyme level of Wistar rats administered extracts of S. jollyanum
|
Groups |
SERUM |
MUSCLE TISSUE |
||
|
LDH (u/l) |
CK (u/l) |
LDH (u/l) |
CK (u/l) |
|
|
Group 1 (Control) |
14.67±4.37a |
3.33±1.81a |
||
|
Group 2(500mg/kgbw) |
51.33±12.46b |
14.47±0.25a |
30.90±1.42a |
4.10±0.56a |
|
Group 3(1000) |
47.17±0.40a |
15.83±2.61a |
34.10±1.85a |
|
|
Group 4(1500) |
41.87±1.31a |
4.53±2.21a |
||
|
Group 5(2000) |
51.47±3.35b |
15.03±4.36a |
32.03±0.89a |
|
|
Group 6(2500) |
46.23±4.37a |
12.27±3.92a |
32.20±1.56a |
3.63±1.53a |
|
Group 7(3000) |
54.20±32.39b |
15.30±2.54a |
32.00±3.11a |
4.13±2.15a |
|
Group 8(3000) |
32.33±3.13a |
3.53±1.74a |
||
Values are expressed as mean ± S. D (n=5)
Values in the
same column bearing different superscript letters differ
significantly(p<0.05) when compared to the control.
Endurance
Parameters
Ideal Body
Weight (g) of Wistar rats administered extracts of S. jollyanum: The Ideal body
weight of the control and the different groups were measured and the results as
shown on Table 2. Except for group 8 which have a significant reduction in body
weight (124.42mg/kg.bw), the result showed that there was no significant
difference between the treated groups (2-7) when compared with the control
(group 1).
Body tissue
weight (Organ weight) of Wistar rats administered extracts of S. jollyanum: The
organ weight of the control and the different groups were measured and the
results as shown on Table 3.
Muscle weight: The
results showed that there was an increase in muscle mass in all treated groups
when compared with the control.
Liver weight: The
results showed that there was a reduction in liver mass of all the treated
groups when compared with the control.
Testes: Except
for group 8(1.79mg/kg.bw), the results showed an increase in testicular size in
all the treated groups when compared with the control. Taken together, there
was a decrease in liver organ weight but an increase in both muscle and testes
organ weight. These may lean to the ergogenic potential of the herb.
Endurance
Parameter of Wistar rats administered extracts of S. jollyanum
Anti-fatigue
capacity (Swimming method): The results (as shown in table 4.10) showed a
progressive increase in antifatigue capacity in all the treated groups when
compared with the control.
Group 1 showed
the lowest antifatigue capacity(513minutes) while group 8 showed the highest
antifatigue capacity(10680minutes).
Table 2: Ideal
Body Weight (g) of Wistar rats administered extracts of S. jollyanum
|
Groups(mg/kgbw) |
Body weight (g) |
|
1 (Control) |
155.77±0.62a |
|
2(500) |
152.49±0.20a |
|
3(1000) |
154.76±0.23a |
|
4(1500) |
142.99±0.30a |
|
5(2000) |
159.50±0.31a |
|
6(2500) |
141.49±0.22a |
|
7(3000) |
147.76±0.00a |
|
8(3500) |
124.42±0.10b |
Values are
expressed as mean ± S. D (n=5)
Values in the
same column bearing different superscripts letters differ
significantly(p<0.05) when compared to control
Table 3: Body Weight (Organ weight) of Wistar rats administered extracts of S. jollyanum
|
Groups |
Organ weight (mg/kg b.w) |
||
|
Muscle |
Liver |
Testes |
|
|
1 |
2.75 |
7.08 |
1.93 |
|
2(500) |
4.22 |
4.46 |
2.46 |
|
3(1000) |
4.97 |
4.91 |
2.24 |
|
4(1500) |
5.49 |
4.05 |
2.32 |
|
5(2000) |
5.57 |
5.02 |
2.27 |
|
6(2500) |
4.86 |
4.26 |
2.25 |
|
7(3000) |
7.08 |
4.70 |
2.29 |
|
8(3500) |
4.73 |
4.80 |
1.79 |
|
Groups |
Time to fatigue(s) |
|
1 (placebo) |
513 |
|
2(500mg/kgbw) |
1166 |
|
3(1000mg/kgbw) |
1646 |
|
4(1500mg/kgbw) |
2538 |
|
5(2000mg/kgbw) |
3332 |
|
6(2500mg/kgbw) |
1976 |
|
7(3000mg/kgbw) |
2601 |
|
8(3500mg/kgbw) |
10680 |
Oxidative
stress, characterized by an imbalance between reactive oxygen species (ROS)
production and antioxidant defense mechanisms, plays a critical role in the
pathogenesis of numerous chronic diseases, including diabetes, cardiovascular
disorders, neurodegenerative diseases, and cancer (Valko et al., 2007; Liguori
et al., 2018). The present study demonstrated that administration of S.
jollyanum extract resulted in a significant enhancement of endogenous
antioxidant enzymes such as superoxide dismutase (SOD), catalase (CAT), and
glutathione peroxidase (GPx), alongside an increase in reduced glutathione
(GSH) levels. These enzymes are fundamental components of the cellular
antioxidant defense system, responsible for detoxifying superoxide radicals and
hydrogen peroxide, thereby preventing oxidative damage to biomolecules
(Halliwell & Gutteridge, 2015).
Additionally,
the study observed a marked reduction in malondialdehyde (MDA) levels, a
well-established biomarker of lipid peroxidation and oxidative damage. The
decrease in MDA levels suggests that the ethanolic extract effectively inhibits
lipid peroxidation processes, thereby preserving cellular membrane integrity.
This finding is consistent with previous reports that plant-derived antioxidants
can attenuate oxidative damage by scavenging free radicals and stabilizing
cellular structures (Pham-Huy et al., 2008; Omoyajowo et al., 2025).
The observed
antioxidant effects of Sphenocentrum jollyanum can be attributed to its rich
phytochemical composition, particularly the presence of flavonoids, alkaloids,
tannins, and saponins, which are known to exhibit strong free radical
scavenging and metal-chelating activities. These phytoconstituents likely act
synergistically to enhance antioxidant enzyme activity and reduce oxidative
stress (Ijeh & Ejike, 2011; Akinmoladun et al., 2019).
Furthermore, the
dose-dependent response observed in this study indicates that higher
concentrations of the extract confer greater antioxidant protection, suggesting
a direct relationship between phytochemical concentration and biological
activity. This aligns with findings from previous experimental studies in
Wistar rats, where S. jollyanum extracts improved antioxidant status and
reduced oxidative damage in various pathological models (Mbaka et al., 2019;
Adeleke et al., 2024).
Importantly, the
use of ethanolic extraction in this study proved effective in isolating
bioactive compounds responsible for antioxidant activity. Ethanol, as a
solvent, facilitates the extraction of both polar and moderately non-polar
compounds, thereby enhancing the pharmacological potency of the extract (Ugwu
& Alum, 2023).
Conclusion
The present
study investigated the effect of ethanolic extract of Sphenocentrum jollyanum on
antioxidant enzymes as biomarkers of oxidative stress in Wistar rats. The
findings of this research provide compelling evidence that the ethanolic
extract of Sphenocentrum jollyanum possesses significant antioxidant properties
capable of modulating oxidative stress in vivo. Overall, the findings of this
study validate the traditional medicinal use of Sphenocentrum jollyanum and
provide scientific evidence supporting its potential as a natural antioxidant
agent. The extract demonstrated significant efficacy in modulating oxidative
stress biomarkers, suggesting its possible application in the prevention and
management of oxidative stress-related diseases.
References
Adeleke, O. V.,
Adefegha, S. A., Molehin, O. R., Olowoleye, A. T., & Oboh, G. (2024).
Anti-hyperglycemic and antioxidative effects of aqueous extracts from Sphenocentrum jollyanum:
Evidence from in vitro and in vivo studies. Tropical
Journal of Natural Product Research, 8(9), 8498–8503.
Ashamu, E. A.,
Adebayo, T. O., Siyanbade, J. A., Adekunle, O. M., Olaniyan, I. O., &
Olalere, A. N. (2025). Efficacy of zinc sulphate on fertility detrimental
effects of methanol extract of Sphenocentrum
jollyanum root in male Wistar rats. Asian Journal of Research in Medical and Pharmaceutical
Sciences, 14(2), 105–119.
Bahekar, S. E.,
& Kale, R. S. (2016). Evaluation of antioxidant activity of Manihot esculenta Crantz in
Wistar rats. Journal of Pharmacy
and Bioallied Sciences, 8(1), 45–49.
Mbaka, G. O.,
Ogbonnia, S., Sulaiman, A., & Osiagwu, D. (2019). Histomorphological
effects of the oil extract of Sphenocentrum
jollyanum seed on benign prostatic hyperplasia induced in Wistar
rats. Avicenna Journal of
Phytomedicine, 9(1), 21–33.
Olorunnisola,
O. S., Akintola, A. O., & Afolayan, A. J. (2011). Hepatoprotective and
antioxidant effect of Sphenocentrum
jollyanum stem bark extract against CCl₄-induced oxidative stress
in rats. African Journal of
Pharmacy and Pharmacology, 5(9), 1241–1246.
Olorunnisola,
O. S., & Afolayan, A. J. (2013). In vivo antioxidant and biochemical
evaluation of Sphenocentrum
jollyanum leaf extract in Plasmodium
berghei-infected mice. Pakistan
Journal of Pharmaceutical Sciences, 26(3), 445–450.
Omoyajowo, O.
O., Ajayi, O. B., Olanlokun, J. O., Ajayi, O. O., & Alli Smith, Y. R.
(2025). Sphenocentrum jollyanum
aqueous leaf extract demonstrates anti-inflammatory and
mitochondrial-restorative influences in diabetic Wistar rats. Journal of Ethnopharmacology, 345,
119605.
Raji, Y.,
Fadare, O. O., Adisa, R. A., & Salami, S. A. (2006). Comprehensive
assessment of the effect of Sphenocentrum
jollyanum root extract on male reproductive activity in rats. African Journal of Biotechnology, 5(20),
1900–1905.
Ugwu, O. P. C.,
& Alum, E. U. (2023). Ethanol root extract and fractions of Sphenocentrum jollyanum
abrogate hyperglycaemia in streptozotocin-induced diabetic Wistar rats. RPS Pharmacy and Pharmacology Reports, 2(2),
rqad010.
How to Cite This Article
Ekpoikong,
U. E., Wegwu, M. O. and Ogunka-Nnoka, C. U. (2026). Effect
of Ethanolic Extract of Sphenocentrum Jollyanum on Antioxidant Enzymes as
Biomarkers of Oxidative Stress in Wistar Rats. Carl Advance Multidisciplinary, 3(1), 01-08. https://doi.org/10.70726/cam.2026.6583001
